Saturday, October 28, 2017

New drug-testing tech could drastically cut animal testing.

New drug-testing tech could drastically cut animal testing.Israeli human-on-a-chip platform has the unique ability to predict risk of toxicity in pharma and cosmetic product candidates without animal testing. After spending an average of $2.5 billion to develop a single new drug, sometimes pharma companies have to pull it from the market due to a bad outcome that was not detected in clinical studies.That’s what happened in 2000, when a promising Type 2 diabetes drug called troglitazone led to idiosyncratic (unexplained) liver damage in one of every 60,000 users. The troglitazone mystery wasn’t solved until March 2016, when a novel “liver-on-a-chip” platform developed by Hebrew University of Jerusalem Prof. Yaakov Nahmias revealed what no animal or human tests could: even low concentrations of this drug caused liver stress before any damage could be seen. “It was the first time an organ-on-chip device could predict information to help pharmaceutical companies define risk for idiosyncratic toxicity,”

No comments:

Post a Comment

Agribusiness ideas.

Agribusiness Millionaires

Agribusiness Millionaires
Learn how to make money in agribusiness.

Popular Posts

AGRIBUSINESS EDUCATION.

Translate

I-CONNECT -AGRICULTURE

AGRIBUSINESS TIPS.

AGRIBUSINESS.

The Agriculture Daily

veterinarymedicineechbeebolanle-ojuri.blogspot.com Cassava: benefits of garri as a fermented food. Cassava processing involves fermentation which is a plus for gut health. The fermentation process removes the cyanogenic glucosides present in the fres...

Claim your bonus here..

Claim your bonus here..
Free dog care guide.

CASSAVA BUSINESS

CASSAVA BUSINESS
CASSAVA FLAKES.